Autolus Therapeutics (AUTL) Net Cash Flow (QoQ) (2018 - 2025)
Autolus Therapeutics (AUTL) Net Cash Flow (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 151.05% |
| Sep 30, 2025 | -252.58% |
| Jun 30, 2025 | 116.55% |
| Mar 31, 2025 | 65.49% |
| Dec 31, 2024 | -354.49% |
| Sep 30, 2024 | -59.52% |
| Jun 30, 2024 | -110.38% |
| Mar 31, 2024 | 2,079.66% |
| Dec 31, 2023 | 36.93% |
| Sep 30, 2023 | 2.51% |
| Jun 30, 2023 | 8.51% |
| Mar 31, 2023 | -122.43% |
| Dec 31, 2022 | 639.68% |
| Sep 30, 2022 | -15.40% |
| Jun 30, 2022 | 6.58% |
| Mar 31, 2022 | -126.20% |
| Dec 31, 2021 | 451.88% |
| Sep 30, 2021 | -58.09% |
| Jun 30, 2021 | -129.22% |
| Mar 31, 2021 | 356.27% |